erytech
Lyon
About erytech
ERYtech Pharma specializes in the encapsulation of therapeutic molecules and enzymes in red blood cells. It has achieved a major breakthrough in the fields of cancer and enzyme therapy by significantly increasing the therapeutic index of the encapsulated molecule or enzyme.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $227.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Dec 2021)
- Ticker: epa:ERYP
- Website: erytech.com
- Phone: 33(0)4-78-74-44-38
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical, Oncology
Social Profiles
Canonical: https://fsome.com/organization/erytech-156742 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.